Special Issues
Future Pharmacology publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
Drugs, Growth Factors and Active Molecules for Tissue Engineering and Regenerative Medicine
Deadline: 30 November 2026
Feature Papers in Future Pharmacology 2026
Deadline: 30 November 2026
Phytochemicals in Cancer Prevention and Treatment: A Multidisciplinary Perspective
Deadline: 31 December 2026
Novel Therapeutic Agents and Innovative Treatment Strategies Against Infectious Diseases
Deadline: 20 January 2027
Dual-Action Metal Complexes: Emerging Approaches in Pharmacology and Pharmaceutics
Deadline: 28 February 2027
Pharmacology and Toxicology of Psychoactive Substances: From Molecules to the Clinic
Deadline: 28 February 2027
Pharmacology in the Era of Artificial Intelligence: From Synthetic Molecules to Natural Products and Personalized Therapies
Deadline: 30 April 2027
Transdiagnostic Psychopharmacology: Bridging Mechanisms Across Mental Disorders
Deadline: 30 June 2027
Current and Future Pharmacochemical Strategies for Cancer Targeting
Deadline: 30 June 2027
Natural Products in Future Pharmacology: Biological Activities, Mechanisms of Action, and Therapeutic Potential
Deadline: 31 August 2027
Recent Advances in the Discovery of Anti-Inflammatory Compounds
Deadline: 31 October 2027

